# Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema

> **NCT07012642** · EARLY_PHASE1 · RECRUITING · sponsor: **Advanced Reconstructive Surgery Alliance** · enrollment: 110 (estimated)

## Conditions studied

- Lymphedema

## Interventions

- **DRUG:** GLP-1 Receptor Agonists

## Key facts

- **NCT ID:** NCT07012642
- **Lead sponsor:** Advanced Reconstructive Surgery Alliance
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-09
- **Primary completion:** 2027-04-09
- **Final completion:** 2027-04-09
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2025-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07012642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07012642, "Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT07012642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*